Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cognitive decline and hypertension].

A S Rigaud1, L Traykov, O Hanon

  • 1Hôpital Broca, CHU Cochin Port-Royal, Université René Descartes, Paris V, 54/56, rue Pascal, 75013 Paris. anne-sophie.rigaud@brc.ap-hop-paris.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux
|March 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perspectives of French community-dwelling older adults on the use of digital services: a qualitative study based on interviews.

BMC geriatrics·2026
Same author

Primary Impact Trajectories of a Psychoeducational Program for Nursing Home Caregivers: Insights from Clinical Case Studies.

International medical case reports journal·2025
Same author

The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort.

Revue neurologique·2024
Same author

[Translation into French and republication of: "Management of cancer-associated thromboembolism in vulnerable population"].

La Revue de medecine interne·2024
Same author

The free plasma amyloid Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio. The BALTAZAR study.

Neurobiology of disease·2024
Same author

Orthostatic hypotension: Review and expert position statement.

Revue neurologique·2023
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Hypertension is a significant risk factor for both vascular and degenerative dementias, including Alzheimer's disease. Treating high blood pressure may help reduce dementia incidence, warranting further research into effective treatments.

Area of Science:

  • Neurology
  • Gerontology
  • Cardiovascular Medicine

Context:

  • Dementia prevalence and incidence rise sharply with age.
  • Hypertension is increasingly recognized as a risk factor for various dementia types.
  • Alzheimer's disease and vascular dementia share common risk factors with hypertension.

Purpose:

  • To explore the link between hypertension and dementia.
  • To investigate the potential of hypertension treatment in dementia prevention.
  • To highlight the significance of the Syst-Eur study findings.

Summary:

  • Age-related dementia, including Alzheimer's disease and vascular dementia, is a growing concern.
  • Emerging research links hypertension to increased risk for both vascular and degenerative dementias.

Related Experiment Videos

  • The Syst-Eur study indicated that nitrendipine, a calcium channel blocker, may reduce stroke and dementia incidence, suggesting a therapeutic target.

    • Impact:

    • Hypertension management may offer a novel strategy for dementia prevention.
    • Further confirmation of the Syst-Eur study is crucial for clinical practice guidelines.
    • This research underscores the importance of cardiovascular health in cognitive aging.